Pharmabiz

Boehringer Ingelheim presents positive data from phase III FIBRONEER programme on nerandomilast in risk of death in IPF and PPF at ERS Congress

Ingelheim, Germany Tuesday, September 30, 2025, 14:00 Hrs [IST] ...
Pharmabiz

FIP empowers pharmacists in cardiovascular care with new Hypertension Pharmacy Toolkit

FIP empowers pharmacists in cardiovascular care with new Hypertension Pharmacy Toolkit: Our Bureau, Bengaluru Tuesday, September 30, 2025, 13:45 Hrs [IST] International Pharmaceut ...
Pharmabiz

GSK appoints Luke Miels as CEO designate

GSK plc announces that Luke Miels is appointed CEO designate, GSK. He will assume full responsibilities as CEO and join the ...
Pharmabiz

BioArctic’s partner Eisai receives China NMPA approval for Leqembi IV maintenance dosing to treat early Alzheimer’s disease

BioArctic’s partner Eisai receives China NMPA approval for Leqembi IV maintenance dosing to treat early Alzheimer’s disease: Stockholm Tuesday, September 30, 2025, 12:00 Hrs [ ...
Pharmabiz

WHO COPCORD survey reveals 1 in 6 Indians living with arthritis, call for a National Action Plan

Our Bureau, Bengaluru Tuesday, September 30, 2025, 10:00 Hrs [IST] ...
Pharmabiz

Genmab to acquire clinical-stage biotechnology company, Merus for USD 8 billion

Genmab to acquire clinical-stage biotechnology company, Merus for USD 8 billion: Copenhagen, Denmark Tuesday, September 30, 2025, 09:00 Hrs [IST] Genmab A/S and Merus N.V. announc ...
Pharmabiz

Indian pharma cos to benefit as drugs worth $236 billion expected to go off-patent in next five years

Nandita Vijayasimha, Bengaluru Tuesday, September 30, 2025, 08:00 Hrs [IST] ...
Pharmabiz

Bombay HC strikes down blanket stop-production orders issued against two pharma cos by Maharashtra FDA

Peethaambaran Kunnathoor, Chennai Tuesday, September 30, 2025, 08:00 Hrs [IST] ...
Pharmabiz

US 100% tariff on branded pharma products unlikely to have any impact on Indian generic drug exports: Industry experts

Shardul Nautiyal, Mumbai Tuesday, September 30, 2025, 08:00 Hrs [IST] ...
Pharmabiz

PCI refuses permission to 89 institutions in Maharashtra for 1st year admission for AY 2025-26

Our Bureau, New Delhi Tuesday, September 30, 2025, 08:00 Hrs [IST] ...
Pharmabiz

MDC seeks clarity on application for exemption of nafithromycin from DPCO

MDC seeks clarity on application for exemption of nafithromycin from DPCO: Gireesh Babu, New Delhi Tuesday, September 30, 2025, 08:00 Hrs [IST] The Multidisciplinary Committee of ...
Pharmabiz

NIHR-supported study of new gene therapy treatment for Huntington's disease shows positive results

NIHR-supported study of new gene therapy treatment for Huntington's disease shows positive results: United Kingdom Monday, September 29, 2025, 18:00 Hrs [IST] An NIHR-supported st ...